|
|||
Loss |
How long did you take the drug before you got the desired result? |
Here is the some steps to help you to save money on Loss purchase.
Read drug prescription
What is Loss
Loss sodium is a bisphosphonate that acts as a specific inhibitor of osteoclast-mediated bone resorption. Bisphosphonates are synthetic analogs of pyrophosphate that bind to the hydroxyapatite found in bone.Loss sodium tablets are indicated for:
- Treatment and prevention of osteoporosis in postmenopausal women
- For the treatment of osteoporosis, Loss sodium tablets increases bone mass and reduce the incidence of fractures, including those of the hip and spine (vertebral compression fractures). Osteoporosis may be confirmed by the finding of low bone mass (for example, at least 2 standard deviations below the premenopausal mean) or by the presence or history of osteoporotic fracture. (See CLINICAL PHARMACOLOGY, Pharmacodynamics.)
- For the prevention of osteoporosis, Loss sodium tablets may be considered in postmenopausal women who are at risk of developing osteoporosis and for whom the desired clinical outcome is to maintain bone mass and to reduce the risk of future fracture.
Bone Loss is particularly rapid in postmenopausal women younger than age 60. Risk factors often associated with the development of postmenopausal osteoporosis include early menopause; moderately low bone mass (for example, at least 1 standard deviation below the mean for healthy young adult women); thin body build; Caucasian or Asian race; and family history of osteoporosis. The presence of such risk factors may be important when considering the use of Loss sodium tablets for prevention of osteoporosis.
- Treatment to increase bone mass in men with osteoporosis.
- Treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density (see PRECAUTIONS, Glucocorticoid-induced osteoporosis). Patients treated with glucocorticoids should receive adequate amounts of calcium and vitamin D.
- Treatment of Paget's disease of bone in men and women
- Treatment is indicated in patients with Paget's disease of bone having alkaline phosphatase at least two times the upper limit of normal, or those who are symptomatic, or those at risk for future complications from their disease.
Loss is usually used to treat osteoporosis. Some of the most prescribed drugs in this class include: Loss; Actonel; Evista; Forteo; Boniva.
Select the most affordable brand or generic drug
References
- Dailymed."Alendronate sodium: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
- "Alendronic acid". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
- "Alendronic acid". http://www.drugbank.ca/drugs/DB0063... (accessed August 28, 2018).
Loss - Frequently asked Questions
Can Loss be stopped immediately or do I have to stop the consumption gradually to ween off?
In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.
It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.
Can Loss be taken or consumed while pregnant?
Please visit your doctor for a recommendation as such case requires special attention.
Can Loss be taken for nursing mothers or during breastfeeding?
Kindly explain your state and condition to your doctor and seek medical advice from an expert.
Reviews
Following the study conducted by gmedication.com on Loss, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Loss. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.Patient reports
Patient reported useful
No survey data has been collected yetPatient reported side effects
No survey data has been collected yetPatient reported price estimates
No survey data has been collected yetPatient reported frequency of use
No survey data has been collected yetPatient reported doses
No survey data has been collected yetPatient reported time for results
No survey data has been collected yetPatient reported administration
No survey data has been collected yetPatient reported age
No survey data has been collected yetPatient reviews
There are no reviews yet. Be the first to write one! |
The information was verified by Dr. Vishal Pawar, MD Pharmacology